Breast MRI screening in patients with increased familial and/or genetic risk for breast cancer: A preliminary experience

Tumori

Volumn 89, Issue 2, 2003, Pages 125-131

  Trecate, Giovanna ^a   Vergnaghi, Daniele ^a   Bergonzi, Silvana ^a   De Simone, Tiziana ^a   Fengoni, Elena ^a   Costa, Claudia ^a   Spatti, Gianbattista ^a   Pasini, Barbara ^a   Manoukian, Siranoush ^a   Podo, Franca ^b   Musumeci, Renato ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

BRCA1 2; Breast cancer; Breast magnetic resonance imaging; Optimized screening

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FAMILIAL CANCER; FEMALE; GENETIC RISK; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; RISK FACTOR;

EID: 0038545836     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900204     Document Type: Article

References (21)

1. National Cancer Institute. SEER cancer statistics rewiew, 1973-1995: section 4-breast. Female breast cancer: trends in SEER incidence and US mortality. Available at: http://wwwseer.ims.nci.nhi.gov/Publications/CSR7395/breast .pdf. Accessed February 2, 2000.
2. Lynch HT, Albano WA, Danes BS, Layton MA, Kimberling WJ, Lynch JF, Cheng SC, Costello KA, Mulcahy GM, Wagner CA: Genetic predisposition to breast cancer. Cancer, 53: 612-622, 1984.
3. Chang-Claude J, Becher H, Hamann U, Schroder KT: Risikoabschatzung fur das familiare auftreten von brustkrebs. Zentralb Gynakol, 117: 423-434, 1995.
4. Bick U: An integrated early detection concept in women with a genetic predisposition for breast cancer. Radiologe, 37: 591-596, 1997.
5. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266: 66-71, 1994.
6. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature, 378: 789-792, 1995.
7. Claus EB, Schildkraut JM, Thompson WD, Risch NJ: The genetic attributable risk of breast and ovarian cancer. Cancer, 77: 2318-2324, 1996.
8. Easton DF, Bishop DT, Ford D, Crockford GP, and Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet, 52: 678-701, 1993.
9. De Michele A, Weber BL: Inherited genetic factors. In: Disease of the breast, Harris JR, Lippman ME, Morrow M (Eds), pp 221-236, Lippincott Williams and Wilkins, Philadelphia, 1999.
10. Johannsson OT, Idvall I, Anderson C, Borg A, Barkardottir RB, Egilsson V, Olsson H: Tumor biological features of BR-CA1 induced breast and ovarian cancer. Eur J Cancer, 33: 362-371, 1997.
11. Foulkes WD, Wong N, Rozen F, Brunet JS, Narod SA: Survival of patients with breast cancer and BRCA1 mutations. Lancet, 351: 1359-1360, 1998.
12. Hartmann LC, Schaid DJ, Woods JE: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl Med, 340: 77-84, 1999.
13. Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, Maringa M, Pfeifer U, Krebs D, Schild HH: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology, 215: 267-279, 2000.
14. Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI: Prevention with tamoxifen or other hormones versus prophylatic surgery in BRCA1/2-positive women: a decision analysis. Cancer J Sci Am, 6: 13-20, 2000.
15. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH: Dynamic breast MR imaging: are signal time course data useful for differential diagnosis of enhancing lesions in dynamic breast MR imaging? Radiology, 211: 101-110, 1999.
16. Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT: BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA-repair. J Biol Chem, 274: 1808-1812, 1999.
17. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature, 386: 804-810, 1997.
18. Beemsterboer PM, Warmerdam PG, Boer R, de Koning HJ: Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen, 5: 81-87, 1998.
19. Jackson V: The role of US in breast imaging. Radiology, 177: 305-311, 1990.
20. Trecate G, Tesoro-Tess JD, Vergnaghi D, Bergonzi S, Mariani G, Ferraris C, Musumeci R: Lobular breast cancer: how useful is breast magnetic resonance imaging? Tumori, 87: 232-238, 2001.
21. Boetes C, Stoutjesdijk M: MR imaging in screening women at increased risk for breast cancer. Magn Reson Imaging Clin N Am, 2: 357-372, 2001.